Neurofeedback Systems Market By System Type (Frequency/Power Neurofeedback Systems, Slow Cortical Potential Neurofeedback (SCP-NF), Low-Energy Neurofeedback Systems (LENS), Hemoencephalographic (HEG) Neurofeedback Systems, Low-Resolution Electromagnetic Tomography (LORE-TA) and Functional Magnetic Resonance Imaging (fMRI)), By Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety Disorders, Pain Management, Insomnia and Other Applications), By End User (Hospitals, Physician Offices, Ambulatory Surgical Centers (ASCs), Home Care, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

The Neurofeedback Systems Market size is expected to be worth around US$ 2.97 billion by 2034 from US$ 1.48 billion in 2024, growing at a CAGR of 7.2% during the forecast period 2025 to 2034. North America held a dominant market position, capturing more than a 39.2% share and holds US$ 580.2 Million market value for the year.

Neurofeedback is a technique that helps individuals consciously regulate their brain waves. During this process, the individual aims to enhance brain patterns by responding to changes in auditory or visual stimuli. The primary focus of neurofeedback treatment protocols is on brainwave frequencies such as alpha, beta, delta, theta, and gamma, or a combination of these, such as the alpha/theta ratio or beta/theta ratio.

The market is experiencing growth as the awareness about mental health is increasing with also advancements in technology. These systems trains individuals to regulate the brain activity which is gaining popularity in the healthcare systems. As the cases of mental health disorders such as ADHD, anxiety, depression, and PTSD keeps on increasing, the demand for neurofeedback systems is also rising.  Advancements in neuroimaging technology and the development of next-generation devices are enhancing the effectiveness and accessibility of neurofeedback therapy. These innovations are expanding the application of neurofeedback beyond clinical settings into areas like cognitive enhancement and peak performance.

According to the World Health Organization (WHO), nearly one in eight individuals worldwide—approximately 970 million people—are affected by mental disorders. These include anxiety and depressive disorders, which are the most common. About 301 million people live with anxiety disorders, including 58 million children and adolescents. Additionally, 280 million people suffer from depression, affecting 23 million young individuals. Around 40 million people globally experience bipolar disorder. These figures highlight the widespread impact of mental health conditions across all age groups and underscore the urgent need for accessible treatment solutions.

Technological progress in neuroimaging and device development is transforming the field of neurofeedback therapy. These innovations are improving treatment effectiveness and making therapies more widely accessible. Modern neurofeedback systems now support real-time brain activity monitoring with higher precision. As a result, the use of neurofeedback is expanding beyond medical treatment into new areas. It is increasingly applied in cognitive performance enhancement, learning optimization, and peak mental training. This shift indicates a broader acceptance of neurofeedback across both clinical and non-clinical settings. Such advancements are expected to drive future adoption and increase market demand.

Key Takeaways

• In 2024, the market for Neurofeedback Systems generated a revenue of US$ 1.48 billion, with a CAGR of 7.2%, and is expected to reach US$ 2.97 billion by the year 2034.
• Based on System Type segment Frequency/Power Neurofeedback Systems taking the lead in 2024 with a market share of 39.8%.
• By Application, the market is bifurcated into Attention Deficit Hyperactivity Disorder (ADHD), Anxiety Disorders, Pain Management, Insomnia, and Other Applications, with Attention Deficit Hyperactivity Disorder (ADHD) the market with 29.9% of market share in 2024.
• Considering the end user segment, the market is bifurcated into Hospitals, Physician Offices, Ambulatory Surgical Centers (ASCs), Home Care, and Others, with Hospitals taking the lead in 2024 with 34.9% market share.
• North America led the market by securing a market share of 39.2% in 2024.

System Type Analysis

Frequency/Power Neurofeedback Systems dominated the market in 2024 with 39.8% market share. These systems focuses on regulating brain wave frequencies by providing real-time feedback based on the power or amplitude of specific brain waves. It is widely used for addressing conditions like ADHD, anxiety, depression, and sleep disorders.

Frequency/Power Neurofeedback has become the go-to system due to its proven efficacy in enhancing cognitive performance, emotional regulation, and overall mental wellness. The system works by training the brain to produce desirable brainwave patterns (such as increased alpha or beta waves) while reducing unwanted ones (like theta waves). It is highly effective for improving focus, relaxation, and stress management.

Moreover, the simplicity and versatility of frequency-based neurofeedback systems make them accessible for both clinical and at-home use. This accessibility, combined with positive outcomes reported in numerous clinical studies, contributes to their dominance in the market. With growing awareness of mental health and cognitive enhancement, the demand for these systems is expected to continue expanding, solidifying their position as the market leader.

Application Analysis

Attention Deficit Hyperactivity Disorder (ADHD) led the market in 2024 with 29.9% market share, as these systems has shown significant promise in treating ADHD by training individuals to regulate brain activity, particularly in areas responsible for attention and focus. ADHD is one of the most common neurodevelopmental disorders, affecting millions worldwide, which has led to increased demand for effective, non-invasive treatment options like neurofeedback.

Studies have also demonstrated that neurofeedback can help individuals with ADHD increase focus, reduce impulsivity, and improve overall behaviour with recent developments happening as a result. It targets specific brainwave patterns associated with hyperactivity and inattention, enabling patients to self-regulate and achieve better cognitive performance. Neurofeedback offers an alternative to traditional medication treatments, which can have side effects, making it an appealing option for many families and clinicians.

As per a report by CDC, in 2022, a national survey of parents estimated that approximately 7 million U.S. children, or 11.4%, aged 3–17 years had been diagnosed with ADHD. Compared to 2016, an additional 1 million children in this age group received an ADHD diagnosis by 2022. Despite this, nearly 2 million children with ADHD in the U.S. did not receive ADHD-specific treatment in 2022.

The growing prevalence of ADHD, combined with the rising preference for non-pharmaceutical interventions, has fueled the adoption of neurofeedback for ADHD. This has led to its dominance in the market, with neurofeedback systems increasingly being integrated into clinical and home-based settings to manage the symptoms of ADHD effectively.

End User Analysis

The dominating segment in the neurofeedback systems market by end user is Hospitals accounting for over 34.9% market share. Hospitals are the primary setting for the use of neurofeedback systems due to their established infrastructure, access to medical professionals, and comprehensive healthcare services. Hospitals often offer specialized neurofeedback therapies for a variety of conditions, such as ADHD, anxiety, depression, and PTSD, under the supervision of trained healthcare providers.

The demand for neurofeedback in hospitals is largely driven by the need for non-invasive treatments for mental health and neurological disorders. Neurofeedback provides an alternative to traditional pharmaceutical treatments, making it appealing in settings where patients seek holistic approaches. Hospitals benefit from the ability to integrate neurofeedback therapy into their broader patient care programs, allowing for multidisciplinary treatment options.

Key Market Segments

By System Type

• Frequency/Power Neurofeedback Systems
• Slow Cortical Potential Neurofeedback (SCP-NF)
• Low-Energy Neurofeedback Systems (LENS)
• Hemoencephalographic (HEG) Neurofeedback Systems
• Low-Resolution Electromagnetic Tomography (LORE-TA)
• Functional Magnetic Resonance Imaging (fMRI)

By Application

• Attention Deficit Hyperactivity Disorder (ADHD)
• Anxiety Disorders
• Pain Management
• Insomnia
• Other Applications

By End User

• Hospitals
• Physician Offices
• Ambulatory Surgical Centers (ASCs)
• Home Care
• Others

Drivers

Growing Awareness of Mental Health

The increasing awareness of mental health challenges and the effectiveness of neurofeedback as a non-invasive therapy is driving the growth of the neurofeedback systems market. Mental health issues such as anxiety, depression, and ADHD are on the rise globally, leading to greater demand for alternative treatments.

According to the National Survey on Drug Use and Health, nearly 1 in 5 U.S. adults experience a mental health condition each year. At the Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS), anxiety and depression were the most common conditions reported by individuals receiving care. In 2024, mood disorders accounted for nearly 40% of all adult outpatient mental health admissions. This data highlights a growing need for accessible mental health services across the U.S., with Oklahoma reflecting national patterns in demand and treatment gaps.

In May 2025, Oklahoma observed Mental Health Awareness Month through statewide events and initiatives aimed at expanding support services. This move was part of a broader effort to address rising mental health concerns. As public awareness increases, more individuals are exploring non-invasive therapies such as neurofeedback. This technique is gaining traction for its ability to manage mental health issues without negative side effects. As a result, the demand for neurofeedback systems is expected to rise. The growing preference for alternative and personalized therapies positions the neurofeedback market for notable growth in the coming years, particularly among individuals seeking long-term mental wellness solutions.

Restraints

High Initial Costs

The high initial costs associated with neurofeedback systems are a significant restraint for market growth. The equipment required for neurofeedback therapy can be expensive, especially for clinical setups. Additionally, specialized training for practitioners adds to the cost. Smaller clinics and individual practitioners may find it difficult to justify the investment in neurofeedback systems. Despite the effectiveness of these therapies, cost remains a barrier for many potential adopters. For instance, a full neurofeedback system could cost anywhere from US$5,000 to US$10,000, making it less accessible for some.

Advanced neurofeedback technology can cost between US$15,000 and US$50,000 with some packages (including software and accessories) reaching US$50,000–US$70,000 for high-precision, FDA-approved systems. Individual state-of-the-art systems for clinical use, such as NeurOptimal, can come with a price tag of over US$10,000, and LoRETA neurofeedback systems with advanced 19-channel EEG setups can cost US$10,000 to US$20,000.

Opportunities

Integration with Wearable Devices

An exciting opportunity for the neurofeedback systems market lies in the integration of these systems with wearable devices. Wearable devices such as smartwatches, EEG headbands, and fitness trackers could offer consumers the ability to monitor and enhance their brain activity remotely. This creates a broader consumer market beyond clinical settings.

For example, companies like Myndlift are already offering smartphone-connected neurofeedback systems that allow users to train their brains at home, thereby expanding accessibility and lowering costs. The growing trend of wearable health technologies presents a significant opportunity to make neurofeedback more mainstream.

In January 2023, Dutch neurofeedback startup Alphabeats partnered with Garmin, a global leader in smartwatches and fitness trackers, to launch a mental training pilot. This initiative targeted professional sports clubs and aimed to enhance mental performance using wearable technology. The partnership was officially announced at the Netherlands Pavilion during CES. Notable attendees included Prince Constantijn van Oranje and Gary Shapiro, CEO of the Consumer Technology Association (CTA). The collaboration highlights the growing role of digital health in elite sports performance.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors have a substantial impact on the neurofeedback market, influencing both demand and accessibility of these high-cost therapeutic systems. During periods of economic growth, increased healthcare spending and greater investment in mental health services support the adoption of advanced neurofeedback technology, driving market expansion at a compound annual growth rate (CAGR) of over 7% between 2025 and 2032. For example, countries with rising healthcare budgets—such as those in North America—show robust market growth, as their advanced infrastructure and insurance coverage help absorb high initial setup costs for clinics and institutions.

Conversely, economic downturns, inflation, or heightened geopolitical tensions (such as trade disputes or sanctions) can constrain patient spending and disrupt the global supply chain for specialized neurofeedback system components. For instance, component shortages due to geopolitical frictions between key technology producers (e.g., US-China trade policy shifts) can increase equipment acquisition costs or delay innovation cycles, impacting smaller clinics and end-users most acutely.

On a positive note, increased government initiatives and global awareness of mental health-often driven by both domestic policy shifts and international diplomatic focus-create a favorable regulatory and reimbursement environment. During the COVID-19 pandemic, for example, heightened stress and mental health awareness led to greater demand for non-invasive, home-based neurofeedback systems, accelerating innovation and adoption worldwide. At the same time, policy support for mental health in regions like the EU, US, and Asia-Pacific is facilitating access and reducing stigma, further fuelling market growth.

Latest Trends

Increasing Use of Neurofeedback in Sports and Performance Enhancement

An emerging trend in the neurofeedback systems market is its use in sports and performance enhancement. Athletes and performers are increasingly using neurofeedback to optimize cognitive function, improve focus, and reduce stress during high-pressure situations. For instance, professional sports teams and individual athletes are using neurofeedback to train mental resilience, manage anxiety, and improve performance consistency.

Neurofeedback is helping athletes like those in the NFL and Olympic teams achieve peak mental performance by providing a way to train brain activity for better concentration and reaction times. This trend reflects the growing recognition of mental fitness as essential for athletic performance.

In April 2023, a systematic study published in NCBI, the researchers concluded that the impact of sports training was verified through the EEG biofeedback method. Research indicates that biofeedback, when incorporated into professional athletes’ training, enhances their ability to manage psychophysiological factors, such as GSR and HR, following stress exposure, ultimately leading to improved well-being.

Regional Analysis

North America is leading the Neurofeedback Systems Market

The neurofeedback systems market in North America is experiencing significant growth with region accounting for 39.2% market share in 2024, driven by increasing demand for non-invasive treatments for neurological and psychological conditions. Key applications include treating conditions such as ADHD, anxiety, depression, and PTSD. Technological advancements and continous research innovations in wearable devices and AI integration are enhancing the accessibility and personalization of neurofeedback therapy.

In October 2020, NASA’s Langley Research Center in Hampton, Virginia, developed a new pair of smart glasses through which one can translate brainwave activity into a measure of attention levels. As automation increasingly took over pilots’ tasks, researchers grew concerned that pilots, being less engaged, might struggle to maintain focus. This technique, rooted in neurofeedback, involves detecting brainwaves and displaying a real-time readout of the user’s brain activity. Through practice, individuals can learn to regulate and control their brainwaves.

In Canada, the market is also expanding, with increasing adoption of neurofeedback systems in clinical settings and wellness centers. The convergence of neuroscience, wearable technology, and artificial intelligence is significantly enhancing the accuracy and personalization of these devices.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

Key players in the Neurofeedback Systems market includes BrainMaster Technologies, Inc., BEE Medic GmbH, Mitsar Co. Ltd., Thought Technology Ltd., Myndlift Ltd., Mindfield Biosystems Ltd., Narbis, NeuroCare Group GmbH, Neurobit Systems, Wearable Sensing, NeuroSky Inc., BrainworksNeurotherapy, InteraXon Inc. (Muse), Mind Media Inc., Neuroelectrics Corporation, and Others.

BrainMaster Technologies, Inc. is a U.S.-based company specializing in advanced neurofeedback and quantitative EEG (qEEG) systems. Their product lineup includes the Freedom Series (dry EEG headsets), Discovery Series (USB-powered systems), and Atlantis I & II models, which support up to 4 channels of EEG and 4 auxiliary biofeedback channels. BrainMaster’s BrainAvatar software offers real-time sLORETA brain imaging, Z-score training, and multimedia feedback, catering to both clinical and research applications.

BEE Medic GmbH, headquartered in Switzerland with operations in Germany and the U.S., develops modular neurofeedback and EEG/ERP diagnostic systems. Their core device, the NeuroAmp II, supports 1–2 channel EEG recordings and integrates with software like Cygnet and BEE Lab for various neurofeedback protocols, including Infra-Low Frequency (ILF), frequency band training, and Slow Cortical Potentials (SCP).

Top Key Players in the Neurofeedback Systems Market

• BrainMaster Technologies, Inc.
• BEE Medic GmbH
• Mitsar Co. Ltd.
• Thought Technology Ltd.
• Myndlift Ltd.
• Mindfield Biosystems Ltd.
• Narbis
• NeuroCare Group GmbH
• Neurobit Systems
• Wearable Sensing
• NeuroSky Inc.
• BrainworksNeurotherapy
• InteraXon Inc. (Muse)
• Mind Media Inc.
• Neuroelectrics Corporation
• Others

Recent Developments

• In June 2025: Myndlift, recognized as a leading provider of expert-guided remote neurofeedback solutions, released an illustrated brainwave guide aimed at improving public understanding of neural activity. The guide draws on extensive data, incorporating insights from more than 1,000,000 neurofeedback sessions and over 20,000 brain scans, offering a comprehensive overview of brainwave patterns and their implications.
• In April 2024: Brain Health announced that it now incorporates QEEG Brain Mapping and Neurofeedback technologies into several of its treatment methods. This latest initiative, inspired by Dr. Ketam Hamdan, aims to enhance the accuracy and effectiveness of mental health treatments over time.
• In September 2022: Myndlift, conducted a retrospective study using real-world data. The study, involving 593 participants, offers preliminary evidence of the effectiveness of remote neurofeedback therapy (NFT) in improving mental health outcomes. Preliminary findings showed a decrease in symptom severity for general psychological health, ADHD, anxiety, and depression from before to after the assessment. Additionally, resting EEG neural markers were adjusted for individuals with ADHD symptoms.

Report Scope